Metharbital

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Metharbital
Metharbital.png
Metharbital ball-and-stick.png
Systematic (IUPAC) name
5,5-diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
Clinical data
AHFS/Drugs.com monograph
Legal status
?
Identifiers
CAS number 50-11-3 YesY
ATC code N03AA30
PubChem CID 4099
DrugBank DB00463
ChemSpider 3957 YesY
UNII 02OS7K758T YesY
KEGG D01382 YesY
ChEMBL CHEMBL450 YesY
Chemical data
Formula C9H14N2O3 
Mol. mass 198.219 g/mol
 YesY (what is this?)  (verify)

Metharbital was patented in 1905 by Emil Fischer working for Merck.[1] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.

History[edit]

  • 1952 Gemonil was introduced by Abbott Laboratories.
  • 1990 Abbott stopped marketing.

Chemistry[edit]

Metharbital (5,5-diethyl-1-methylbarbituric acid) is synthesized by condensation of diethylmalonic ester with methylurea.

  • A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949).
  • Snyder, J. A.; Link, K. P. (1953). Journal of the American Chemical Society 75 (8): 1881. doi:10.1021/ja01104a030.  edit

References[edit]

  1. ^ US Patent 782742